In Mexican Mestizos the HCP5 rs2395029 SNP may be a genetic marker for screening abacavir hypersensitivity-Reference-Cited by-同舟云学术

In Mexican Mestizos the HCP5 rs2395029 SNP may be a genetic marker for screening abacavir hypersensitivity

Published:2012-02 Issue:3 Volume:13 Page:251-252
ISSN:1462-2416
Container-title:Pharmacogenomics
language:en
Short-container-title:Pharmacogenomics

Author:

Sanchez-Giron Francisco¹,Carnevale Alessandra²

Affiliation:

1. Laboratorio Medico Polanco, Insurgentes Sur 1228 3rd Floor, Col. Del Valle, México DF 03100, México

2. Instituto Nacional de Medicina Genómica, 4809 Periférico Sur, Col Arenal Tepepan, México DF 14610, México.

Abstract

A letter in response to: Badulli C, Sestini R, Sbarsi I et al. Tag SNPs of the ancestral haplotype 57.1 do not substitute HLA-B*57:01 typing for eligibility to abacavir treatment in the Italian population. Pharmacogenomics 13(3), 247–249 (2012).

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/pgs.11.169

Reference5 articles.

1. Tag SNPs of the ancestral haplotype 57.1 do not substitute HLA-B*57:01 typing for eligibility to abacavir treatment in the Italian population

2. Association of the genetic marker for abacavir hypersensitivity HLA-B*5701 with HCP5 rs2395029 in Mexican Mestizos

3. NolanD, Thorborn D, Schaefer Met al.Genetic factors predicting abacavir hypersensitivity and tolerance inHLA-B*5701positive individuals: combined analysis from PREDICT-1, SHAPE and a multinational study. Presented at:15th Conference on Retroviruses and Opportunistic Infections. Boston, MA, USA, 3–6 February 2008.

4. TheHCP5Single‐Nucleotide Polymorphism: A Simple Screening Tool for Prediction of Hypersensitivity Reaction to Abacavir

5. Use of the HCP5 single nucleotide polymorphism to predict hypersensitivity reactions to abacavir: correlation with HLA-B*5701

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetic effects of single nucleotide polymorphisms commonly associated with antiretroviral therapy metabolism;HIV Infection and Immunosuppressive Disorders;2022-11-10

2. Validation of two commercial real-time PCR assays for rapid screening of the HLA-B*57:01 allele in the HIV clinical laboratory;Journal of Virological Methods;2016-11

3. The frequency of HLA-B∗57:01 and the risk of abacavir hypersensitivity reactions in the majority population of Costa Rica;Human Immunology;2014-11

4. Development of multiplex pyrosequencing for HLA-B*57:01 screening using single nucleotide polymorphism haplotype;Journal of Clinical Pharmacy and Therapeutics;2014-05-26